Search results
Emcure Pharmaceuticals IPO opens today: GMP, subscription status, review, other details. Apply or...
Livemint· 7 hours agoEmcure Pharmaceuticals IPO subscription opens with ₹582 crore raised from anchor investors. Price...
Shark Tank Judge Namita Thapar To Earn Rs 127 Crore From Emcure IPO
NDTV· 5 hours agoNamita Thapar, the Executive Director of Emcure Pharmaceuticals, is set to earn approximately Rs...
Emcure Pharma IPO: GMP rises sharply ahead of issue opening for subscription on July 3 - CNBC TV18
CNBC TV18· 4 days agoShares of Emcure Pharmaceuticals are trading at a premium of ₹270 in the unlisted market on Saturday...
Emcure Pharmaceuticals IPO opens today | India Infoline
India Infoline· 5 hours agoThe IPO, backed by Bain Capital, has a price band set between ₹960 and ₹1,008 per share and will close on July 5.
Emcure Pharma announces price band for Rs 1,952-crore IPO at Rs 960-1,008/share. Check GMP, other...
The Economic Times· 5 days agoEmcure Pharmaceuticals has set the price band for its upcoming initial public offering (IPO) at Rs...
Post Nifty@24000, is it time for profit-booking? Sunil Subramaniam answers
The Economic Times· 6 days agoSunil Subramaniam, market veteran, says that in April and May, the outflow of Rs 50,000 crore was a...
Emcure Pharma IPO: Issue subscribed 29% on Day 1 so far; NIIs lead from the front
CNBC Awaaz· 6 hours agoA day before the drugmaker's public offer went live, Emcure Pharmaceuticals raised Rs 582.6 crore...
Shark Tank’s Namita Thapar to get Rs 128 crore from Emcure Pharma share sale
Financial Express· 9 hours agoNamita Thapar, one of the judges of the famous TV show Shark Tank India will be partially offloading...
Emcure Pharma IPO opens today: GMP rises; should you subscribe to the issue? - CNBC TV18
CNBC TV18· 8 hours agoThe initial public offering (IPO) of Emcure Pharmaceuticals Ltd. opens for bidding on Wednesday,...
Shark Tank's Namita Thapar to make 293x on her Emcure Pharma exit
CNBC Awaaz· 2 days agoAt the upper end of the price band, Thapar will achieve a 293-fold return. The price band for Emcure...